PF-54590 |
IBUPROFENO Flamingo 400 mg Tabletas recubiertas |
2022-10-27 |
|
Flamingo Pharmaceuticals Ltd |
India
|
Para Farmacias |
Arael de Centro América |
Seven Pharma Guatemala |
Sainsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-54642 |
IBUPROFENO Flamingo 600 mg Tabletas |
2022-11-15 |
|
Flamingo Pharmaceuticals Ltd |
India
|
Para Farmacias |
Arael de Centro América |
Seven Pharma Guatemala |
Sainsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-54698 |
IBUPROFENO Flamingo 800 mg Tabletas recubiertas |
2022-11-22 |
|
Flamingo Pharmaceuticals Ltd |
India
|
Para Farmacias |
Italpharma |
Arael de Centro América |
Seven Pharma Guatemala |
Sainsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-54842 |
CEFIXIMA Lafco 100 mg Cápsulas |
2023-01-18 |
|
Lafco |
India
|
Lafco |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-54875 |
MEROPENEM Flamingo 500 mg Polvo para solución inyectable |
2023-01-24 |
|
Flamingo Pharmaceuticals Ltd |
India
|
Para Farmacias |
Arael de Centro América |
Aarsa |
Eco Energy Pharma |
Seven Pharma Guatemala |
Sainsa |
Ferriepharm |
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-54910 |
CEFALEXINA Lafco125 mg//5 mL Polvo para suspensión oral |
2023-01-31 |
|
Lafco |
India
|
Lafco |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-54916 |
IMIPENEM Y CILASTATINA Flamingo 500 mg + 500 mg Polvo para solución Inyectable |
2023-02-02 |
|
Flamingo Pharmaceuticals Ltd |
India
|
Para Farmacias |
Arael de Centro América |
Eco Energy Pharma |
Seven Pharma Guatemala |
Sainsa |
Ferriepharm |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-54946 |
METFORMINA Flamingo 850 mg tableta recubierta |
2023-02-12 |
|
Flamingo Pharmaceuticals Ltd |
India
|
Para Farmacias |
Arael de Centro América |
Seven Pharma Guatemala |
Sainsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-54993 |
MEROPENEM Flamingo 1 g Polvo para solución inyectable |
2023-03-06 |
|
Flamingo Pharmaceuticals Ltd |
India
|
Arael de Centro América |
Eco Energy Pharma |
Seven Pharma Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55054 |
Rosuvastatina LAFCO 10 mg Tableta Recubierta |
2023-03-16 |
|
Lafco |
India
|
Lafco |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|